Back to Search
Start Over
The importance of the eicosanoid pathway in lung cancer
- Source :
-
Lung Cancer (01695002) . Aug2003 Supplement 1, Vol. 41, pS73. 0p. - Publication Year :
- 2003
-
Abstract
- Non-steroidal anti-inflammatory agents (NSAIDs) inhibit the conversion of arachadonic acid to a class of inflammatory mediators known as eicosanoids. These minimally toxic drugs have demonstrated important anti-cancer properties in colorectal cancer and pre-clinical models have shown their potential for use in the treatment of non-small cell lung cancer (NSCLC). Clinical trials are underway investigating the efficacy of eicosanoid inhibitors alone and in combination with radiation and chemotherapy. [Copyright &y& Elsevier]
- Subjects :
- *ARACHIDONIC acid
*EICOSANOIC acid derivatives
*DRUGS
Subjects
Details
- Language :
- English
- ISSN :
- 01695002
- Volume :
- 41
- Database :
- Academic Search Index
- Journal :
- Lung Cancer (01695002)
- Publication Type :
- Academic Journal
- Accession number :
- 10274173
- Full Text :
- https://doi.org/10.1016/S0169-5002(03)00145-4